Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 317

1.

Symptom clusters as predictors of late response to antidepressant treatment.

Trivedi MH, Morris DW, Grannemann BD, Mahadi S.

J Clin Psychiatry. 2005 Aug;66(8):1064-70.

PMID:
16086624
2.

Fluoxetine treatment of depressed patients with comorbid anxiety disorders.

Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.

J Psychopharmacol. 2002 Sep;16(3):215-9.

PMID:
12236627
3.

Which depressed patients respond to nefazodone and when?

Trivedi MH, Rush AJ, Pan JY, Carmody TJ.

J Clin Psychiatry. 2001 Mar;62(3):158-63.

PMID:
11305700
4.

[Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].

Spadone C, Sylvestre M, Chiarelli P, Richard-Berthe C.

Encephale. 2005 Nov-Dec;31(6 Pt 1):698-704. French.

PMID:
16462689
5.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.

PMID:
19027961
6.

[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].

Mouchabac S, Ferreri M, Cabanac F, Bitton M.

Encephale. 2003 Sep-Oct;29(5):438-44. French.

PMID:
14615693
7.

Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.

Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ.

J Clin Psychiatry. 2008 Aug;69(8):1246-56.

PMID:
18681756
8.

Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.

Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.

CNS Drugs. 2002;16(9):635-43.

PMID:
12153334
9.
10.

Patterns of symptom improvement during antidepressant treatment of delusional depression.

Serretti A, Lattuada E, Zanardi R, Franchini L, Smeraldi E.

Psychiatry Res. 2000 May 15;94(2):185-90.

PMID:
10808044
11.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
12.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
13.

Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.

Jamerson BD, Krishnan KR, Roberts J, Krishen A, Modell JG.

Psychopharmacol Bull. 2003 Spring;37(2):67-78.

PMID:
14566216
14.

Does pretreatment insomnia or anxiety predict acute response to bupropion SR?

Rush AJ, Carmody TJ, Haight BR, Rockett CB, Zisook S.

Ann Clin Psychiatry. 2005 Jan-Mar;17(1):1-9.

PMID:
15941026
15.

The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.

Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE.

Int Clin Psychopharmacol. 2005 Mar;20(2):87-91.

PMID:
15729083
16.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
17.

Testosterone therapy in late-life major depression in males.

Perry PJ, Yates WR, Williams RD, Andersen AE, MacIndoe JH, Lund BC, Holman TL.

J Clin Psychiatry. 2002 Dec;63(12):1096-101.

PMID:
12523867
18.

Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.

Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M.

Psychiatry Res. 2008 Oct 30;161(1):116-20. doi: 10.1016/j.psychres.2008.02.011. Epub 2008 Aug 27.

PMID:
18755514
19.

Mood and neuropsychological changes in women with midlife depression treated with escitalopram.

Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL.

J Clin Psychopharmacol. 2006 Aug;26(4):361-6.

PMID:
16855452
20.

An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.

Lespérance F, Frasure-Smith N, Laliberté MA, White M, Lafontaine S, Calderone A, Talajic M, Rouleau JL.

Can J Psychiatry. 2003 Nov;48(10):695-701.

PMID:
14674053
Items per page

Supplemental Content

Write to the Help Desk